Lipid mediated ER stress contributes to the pathogenesis of mitochondrial myopathies
Molecular Metabolism · 2026-11 · 102472
DOI: 10.1016/j.molmet.2026.102472 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Metabolism, 2026-11. Verfasst von Inaya Laubach und 10 weiteren Autor:innen. Beteiligte Einrichtung: Weill Cornell Medicin, Brain and Mind Research Institute, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS, NINDS.
Abstract (Originalsprache)
Mitochondrial diseases are a heterogeneous group of genetic disorders caused by impaired oxidative phosphorylation (OxPhos). When skeletal muscle is predominantly affected, they are defined as primary mitochondrial myopathies. Although the genetic causes of mitochondrial myopathies and the resulting bioenergetic impairments are well established, the metabolic drivers behind progressive muscle dysfunction remain poorly defined. This gap in knowledge may contribute to the lack of effective treatments for these disorders. OxPhos defective muscle initiates a metabolic response coordinated by systemic signals which results in muscle and adipose tissue wasting. Here, we show ectopic muscle lipid accumulation in a COX10 KO mouse model of mitochondrial myopathy due to inability to oxidize fatty acids in muscle. In both the mouse model and in mitochondrial patients, we find an increase in ceramides, which is mechanistically linked to chronic ER stress, phosphorylation of eIF2α, and activation of ATF4 signaling. We propose that Ph-eIF2α-mediated attenuation of global protein synthesis and ATF4-initiated atrophy pathways contribute to muscle wasting and weakness. Importantly, inhibition of de novo synthesis of ceramides with myriocin reduces ER stress and ATF4 signaling and improves muscle proteostasis, body weight, and motor functions in the COX10 KO mouse. Together, these findings highlight the role of lipid metabolism as a contributor to mitochondrial myopathy and identify lipid-mediated stress pathways that can be targeted therapeutically.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Weill Cornell Medicin, Brain and Mind Research Institute, USA.
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Italy; Dipartimento di Neuroscienze, Università Cattolica del Sacro Cuore, Rome, Italy.
- Department of Pharmacy and Biotechnologies (FaBiT), University of Bologna, Bologna, Italy.
- Department of Pharmacology, New York, NY 10065, USA. Electronic address: qic2005@med.cornell.edu.
- Weill Cornell Medicin, Brain and Mind Research Institute, USA. Electronic address: mad2003@med.cornell.edu.
Förderung
- NIAMS
- NINDS
Zitieren
APA
Laubach, I., Primiano, G., Southwell, N., Rizzardi, N., Yoval-Sánchez, B., Bergamini, C., Servidei, S., Galkin, A., Manfredi, G., Chen, Q., & D'Aurelio, M. (2026). Lipid mediated ER stress contributes to the pathogenesis of mitochondrial myopathies. Molecular Metabolism, 102472. https://doi.org/10.1016/j.molmet.2026.102472
Vancouver
Laubach I, Primiano G, Southwell N, Rizzardi N, Yoval-Sánchez B, Bergamini C, et al. Lipid mediated ER stress contributes to the pathogenesis of mitochondrial myopathies. Molecular Metabolism. 2026:102472. doi:10.1016/j.molmet.2026.102472
BibTeX
@article{Laubach2026,
author = {Laubach, Inaya and Primiano, Guido and Southwell, Nneka and Rizzardi, Nicola and Yoval-Sánchez, Belem and Bergamini, Christian and Servidei, Serenella and Galkin, Alexander and Manfredi, Giovanni and Chen, Qiuying and D'Aurelio, Marilena},
title = {Lipid mediated ER stress contributes to the pathogenesis of mitochondrial myopathies},
journal = {Molecular Metabolism},
year = {2026},
pages = {102472},
doi = {10.1016/j.molmet.2026.102472}
}
EUVIMED